These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1183099)

  • 21. Comparison of haemoglobin levels and blood-transfusion requirements in patients on haemodialysis and on chronic ambulatory peritoneal dialysis.
    Naiker IP; Seedat YK
    S Afr Med J; 1985 Nov; 68(11):785-6. PubMed ID: 4071323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.
    Eschbach JW; Egrie JC; Downing MR; Browne JK; Adamson JW
    N Engl J Med; 1987 Jan; 316(2):73-8. PubMed ID: 3537801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nephrectomy in selected patients with severe refractory hypertension receiving dialysis.
    Briggs WA; Light J; Teichman S; Yeager H; Lowenthal DT; Gibson TP
    Surg Gynecol Obstet; 1975 Aug; 141(2):251-4. PubMed ID: 1154238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malnutrition-inflammation complex syndrome and hepatitis C in maintenance hemodialysis patients.
    Vlatkovic V; Trbojevic-Stankovic J; Stojimirovic B
    Ther Apher Dial; 2009 Apr; 13(2):113-20. PubMed ID: 19379150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of nephrectomy on transfusion requirements of dialysis patients.
    Shaldon S
    Lancet; 1969 Oct; 2(7625):849-50. PubMed ID: 4186308
    [No Abstract]   [Full Text] [Related]  

  • 27. [Testosterone treatment of renal anemia. Evaluation of success by means of morphometric bone marrow and erythrocyte volume determinations].
    Keyssner J; Hauswaldt C; Uhl N; Hunstein W
    Schweiz Med Wochenschr; 1974 Dec; 104(52):1938-41. PubMed ID: 4432057
    [No Abstract]   [Full Text] [Related]  

  • 28. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.
    McGonigle RJ; Wallin JD; Husserl F; Deftos LJ; Rice JC; O'Neill WJ; Fisher JW
    J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver disease in kidney transplant patients receiving azathioprine.
    Ireland P; Rashid A; von Lichtenberg F; Cavallo T; Merrill JP
    Arch Intern Med; 1973 Jul; 132(1):29-37. PubMed ID: 4577390
    [No Abstract]   [Full Text] [Related]  

  • 30. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
    Berria R; Gastaldelli A; Lucidi S; Belfort R; De Filippis E; Easton C; Brytzki R; Cusi K; Jovanovic L; DeFronzo R
    Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men.
    Dobs AS; Meikle AW; Arver S; Sanders SW; Caramelli KE; Mazer NA
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3469-78. PubMed ID: 10522982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals.
    Mueller A; Haeberle L; Zollver H; Claassen T; Kronawitter D; Oppelt PG; Cupisti S; Beckmann MW; Dittrich R
    J Sex Med; 2010 Sep; 7(9):3190-8. PubMed ID: 20584125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum erythropoietin (ESF) titers in anemia of chronic renal failure.
    de Klerk G; Wilmink JM; Rosengarten PC; Vet RJ; Goudsmit R
    J Lab Clin Med; 1982 Nov; 100(5):720-34. PubMed ID: 7130829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of an oral iron chelator, deferasirox, in hemodialysis patients with iron overload.
    Chen CH; Shu KH; Yang Y
    Hematology; 2015 Jun; 20(5):304-10. PubMed ID: 25200910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.
    Miller K; Corcoran C; Armstrong C; Caramelli K; Anderson E; Cotton D; Basgoz N; Hirschhorn L; Tuomala R; Schoenfeld D; Daugherty C; Mazer N; Grinspoon S
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2717-25. PubMed ID: 9709937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuing high morbidity during maintenance hemodialysis consequent to bilateral nephrectomy.
    Rao TK; Manis T; Delano BG; Friedman EA
    Trans Am Soc Artif Intern Organs; 1973; 19():340-4. PubMed ID: 4722750
    [No Abstract]   [Full Text] [Related]  

  • 38. Dialyzer urea and creatinine clearances are not significantly altered in erythropoietin treated maintenance hemodialysis patients.
    Delano BG; Lundin AP; Galonsky R; Quinn-Cefaro RM; Rao TK; Friedman EA
    ASAIO Trans; 1990; 36(1):36-9. PubMed ID: 2306389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis.
    Thamer M; Zhang Y; Kaufman J; Cotter D; Dong F; Hernán MA
    JAMA; 2007 Apr; 297(15):1667-74. PubMed ID: 17440144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.